Nucleic Acid Capture Diomics’ Diomat technology offers enhanced speed, sensitivity, and accuracy in capturing nucleic acids and proteins, presenting a sales angle for diagnostics, forensics, and genomics service providers seeking faster turnaround and lower sample processing costs.

Medical Diagnostics Potential Recent interest in antibody indicators for SARS-CoV-2 signals opportunity to partner with clinical labs, hospitals, and public health organizations looking for extended monitoring tools and reliable serology workflows.

Forensics & Sample Processing The demonstrated complete dissolution of Diomat in extraction solutions can reduce processing steps and time for forensic and medical diagnostic labs, making Diomics attractive to contract labs and government or law enforcement forensic facilities seeking efficiency gains.

Early Stage / Niche Focus With a small team and revenue in the low millions, there is potential for targeted collaborations, pilot programs, or co-development with larger biotech players to scale manufacturing, distribution, and reach into genomics, proteomics, and stem cell research markets.

Tech and Ecosystem Fit Diomics’ technology stack and digital presence align with B2B partnerships; leveraging relationships with instrument providers, contract research organizations, and academic biotech labs can unlock integrated solutions and cross-sell opportunities for sample prep and detection workflows.